Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients. Possible role in the development of proliferative diabetic retinopathy

Diabetes Care

Volumn 25, Issue 12, 2002, Pages 2282-2286

  Simó, Rafael ^a   Lecube, Albert ^a   Sararols, Laura ^a   García Arumí, José ^a   Segura, Rosa M ^a   Casamitjana, Roser ^b   Hernández, Cristina ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PROTEIN; SOMATOSTATIN DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; SOMATOSTATIN;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; HEMOGLOBIN DETERMINATION; HUMAN; PATHOGENESIS; PLASMA; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; SOMATOSTATIN LIKE IMMUNOREACTIVITY; SPECTROPHOTOMETRY; SURGICAL TECHNIQUE; TREATMENT INDICATION; VENOUS BLOOD; VITRECTOMY; VITREOUS BODY; CHEMISTRY; COMPARATIVE STUDY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATHOPHYSIOLOGY;

AGE OF ONSET; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; SOMATOSTATIN; VITRECTOMY; VITREOUS BODY;

EID: 0037599913     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.12.2282     Document Type: Article

References (46)

1. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R: Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77-79, 1973
2. Reichlin S: Somatostatin (Review). N Engl J Med 309:1495-1501, 1983
3. Schoelson SE, Polonsky KS, Nakabayashi T, Jaspan JB, Tager HS: Circulating forms of somatostatin-like immunoreactivity in human plasma. Am J Physiol 250:E428-E434, 1986
4. Patel YC, Geeenwood MT, Warszynska A, Panetta R, Srikant CB: All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun 198:605-612, 1994
5. Lee HK, Suh KI, Koh CS, Min HK, Lee JH, Chung H: Effect of SMS 201-995 in rapidly progressive diabetic retinopathy. Diabetes Care 11:441-443, 1988
6. Mc Combe M, Lightman S, Eckland DJ, Hamilton AM, Lightman SL: Effect of long acting somatostatin analogue (BIM23014) on proliferative diabetic retinopathy: a pilot study. Eye 5:569-575, 1991
7. Mallet B, Vialettes B, Haroche S, Escoffier P, Gastaut P, Taubert JP, Vague P: Stabilization of severe proliferative diabetic retinopathy by long-term treatment with SMS 201-995. Diabete Metab 18:438-444, 1992
8. Kuijpers RW, Baarsma GS, van Hagen PM: Treatment of cystoid macular edema with octreotide. N Engl J Med 338:624-626, 1998
9. Grant MB, Mames RN, Fitzgerald C, Hazariwala KM, Cooper-De Hoff R, Caballero S, Estes KS: The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care 23:504-509, 2000
10. Boehm BO, Lang GK, Jehle PM, Feldman B, Lang GE: Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy. Horm Metab Res 33:300-306, 2001
11. Davis MI, Wilson SH, Grant MB: The therapeutic problem of proliferative diabetic retinopathy: targeting somatostatin receptors. Horm Metab Res 33:295-299, 2001
12. Wilson SH, Davis MI, Caballero S, Grant MB: Modulation of retinal cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy. Growth Horm IGF Res 11 (Suppl. A):S53-S59, 2001
13. Yamaguchi K, Gaur VP, Spira AW, Turner JE: Cellular localization of somatostatin mRNA in rat retina. Neuropeptides 17:13-16, 1990
14. Larsen JN: Somatostatin in the retina. Acta Ophthalmol Scand 218 (Suppl.):1-24, 1995
15. Johnson J, Rickman DW, Brecha NC: Somatostatin and somatostatin subtype 2A expression in the mammalian retina. Microsc Res Tech 50:103-111, 2000
16. Rorstad OP, Senterman MK, Hoyte KM, Matin JB: Immunoreactive and biologically active somatostatin-like material in the human retina. Brain Res 199:488-492, 1980
17. Sagar SM, Marshall PE: Somatostatin-like immunoreactive material in associational ganglion cells of human retina. Neuroscience 27:507-516, 1988
18. Van Hagen PM, Baarsma GS, Mooy CM, Ercoskan EM, ter Averst E, Hofland LJ, Lamberts SW, Kuijpers RW: Somatostatin and somatostatin receptors in retinal diseases. Eur J Endocrinol 143:S43-S51, 2000
19. Lambooij AC, Kuijpers RW, van Lichtenauer-Kaligis EG, Kliffen M, Baarsma GS, van Hagen PM, Mooy CM: Somatostatin receptor 2A expression in choroidal neovascularization secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 41:2329-2335, 2000
20. Helboe L, Moller M: Immunohistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina. Invest Ophthalmol Vis Sci 40:2376-2382, 1999
21. Klisovic DD, O'Dorisio MS, Katz SE, Sall JW, Balster D, O'Dorisio TM, Craig E, Lubow M: Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study. Invest Ophthalmol Vis Sci 42:2193-2201, 2001
22. Lawnicka H, Stepien H, Wyczolkowska J, Kolago B, Kunert-Radek J, Komorowski J: Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture. Biochem Biophys Res Commun 268:567-571, 2000
23. Danesi R, Del Tacca M: The effects of the somatostatin analog octreotide on angiogenesis in vitro. Metabolism 45 (Suppl. 1):49-50, 1996
24. Danesi R, Agen C, Benelli U, Paolo AD, Nardini D, Bocci G, Basolo F, Campagni A, Tacca MD: Inhibition of experimental angigogenesis by somatostatin analogue octeotride acetate (SMS 201-995). Clin Cancer Res 3:265-272, 1996
25. Smith LEH, Kopchick JJ, Chen W, Knapp J, Kinose F, Daley D, Foley E, Smith RG, Schaeffer JM: Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276:1706-1709, 1997
26. Penman E, Wass JAH, Lund A, Lowry PJ, Stewart J, Dawson AM, Besser GM, Rees LH: Development and validation of a specific radioimmunoassay for somatostatin in human plasma. Ann Clin Biochem 16:15-25, 1979
27. Harboe M: A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry. Scand J Clin Lab Invest 11:66-70, 1959
28. Fairbanks VF, Ziesmer SC, O'Brien: Methods for measuring plasma hemoglobin in micromolar concentration. Clin Chem 38:132-140, 1992
29. Burgos R, Mateo C, Cantón R, Hernández C, Mesa J, Simó R: Vitreous levels of IGF-1, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care 23:80-83, 2000
30. Hernández C, Burgos R, Cantón A, García- Arumí, Segura RM, Simó R: Vitreous levels of vascular adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Diabetes Care 24:516-521, 2001
31. Cramer H, Heitzelmann KM: Somatostatin in cerebrospinal fluid after generalized convulsions or cerebral infarction in humans. J Neurol Neurosurg Psychiatry 53:1015-1016, 1990
32. Maeda K, Yasuda M, Kaneda H, Maeda S, Yamadori A: Cerebrospinal fluid (CSF) neuropeptide Y and somatostatin-like immunoreactivities in man. Neuropeptides 27:323-332, 1994
33. Roca CA, Su TP, Elpern S, McFarland H, Rubinow DR: Cerebrospinal fluid somatostatin, mood, and cognition in multiple sclerosis. Biol Psychiatry 46:551-556, 1999
34. Johnson J, Caravelli ML, Brecha NC: Somatostatin inhibits calcium influx into rat rod bipolar cell axonal terminals. Vis Neurosci 18:101-108, 2001
35. Vasilaki A, Gardette R, Epelbaum J, Thermos K: NADPH-diaphorase colocalization with somatostatin receptor subtypes sst2A and sst2B in the retina. Invest Ophthalmol Vis Sci 42:1600-1609, 2001
36. Akopian A, Johnson J, Gabriel R, Brecha N, Witkovsky P: Somatostatin modulates voltage-gated K (+) and Ca (2+) currents in rod and cone photoreceptors of the salamander retina. J Neurosci 20:929-936, 2000
37. Lake N, Patel YC: Neurotoxic agents reduce retinal somatostatin. Brain Res 181:234-236, 1980
38. Dupont E, Christensen SE, Hansen AP, Olivarius BD, Orskov H: Low cerebrospinal fluid somatostatin in Parkinson's disease: an irreversible abnormality. Neurology 32:312-314, 1982
39. Vecsei L, Csala B, Widerlōv E, Ekman R, Czopf J, Palffy G: Lumbar cerebrospinal fluid concentrations of somatostatin and neuropeptide Y in multiple sclerosis. Brain Res Bull 25:411-424, 1990
40. Edvinsson L, Minthon L, Ekman R, Gustafson L: Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration. Dementia 4:167-171, 1993
41. Molchan SE, Hill JL, Martinez RA, Lawlor BA, Mellow AM, Rubinow DR, Bissette G, Nemeroff CB, Sunderland T: CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures. Psychoneuroendocrinology 18:509-519, 1993
42. Smith LE, Shen W, Perruzzi C, Soker K, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR: Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1. Nat Med 5:1390-1395, 1999
43. Grant MB, Caballero S, Millard WJ: Inhibition of IGF-1 and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue, octreotide, a potential treatment for ocular neovascularization. Regul Pept 48:267-278, 1993
44. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H-J, Benedict W, Bouck NP: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245-248, 1999
45. Ogata N, Tombran-Tink J, Nishikawa M, Nishimura T, Mitsuma Y, Sakamoto T, Matsumura M: Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Am J Ophthalmol 132:378-382, 2001
46. Spranger J, Osterhoff M, Reimann M, Möhlig M, Ristow M, Francis MK, Cristofalo V, Hammes HP, Smith G, Boulton M, Pfeiffer AF: Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes 50:2641-2645, 2001